Bernd Gänsbacher

6.9k total citations · 2 hit papers
121 papers, 5.4k citations indexed

About

Bernd Gänsbacher is a scholar working on Genetics, Oncology and Immunology. According to data from OpenAlex, Bernd Gänsbacher has authored 121 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Genetics, 45 papers in Oncology and 42 papers in Immunology. Recurrent topics in Bernd Gänsbacher's work include Virus-based gene therapy research (51 papers), Immunotherapy and Immune Responses (30 papers) and CAR-T cell therapy research (30 papers). Bernd Gänsbacher is often cited by papers focused on Virus-based gene therapy research (51 papers), Immunotherapy and Immune Responses (30 papers) and CAR-T cell therapy research (30 papers). Bernd Gänsbacher collaborates with scholars based in Germany, United States and Italy. Bernd Gänsbacher's co-authors include Karen S. Zier, Eli Gilboa, Rajat Bannerji, Kathy A. Cronin, Martina Anton, Achim Krüger, Christian Plank, J. Henke, Ulrike Schillinger and Franz Scherer and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and The Journal of Experimental Medicine.

In The Last Decade

Bernd Gänsbacher

118 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo

2002 714 citations Martina Anton, Ulrike Schillinger et al. profile →
Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity.

1990 511 citations Bernd Gänsbacher, Karen S. Zier et al. The Journal of Experimental Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bernd Gänsbacher Germany	39	2.1k	1.8k	1.8k	1.7k	577	121	5.4k
Douglas H. Thamm United States	46	1.8k 0.8×	1.7k 0.9×	1.2k 0.7×	1.3k 0.8×	466 0.8×	197	7.7k
Neil Senzer United States	43	3.6k 1.7×	1.7k 1.0×	1.2k 0.7×	3.9k 2.3×	468 0.8×	176	7.8k
Gustav Gaudernack Norway	51	3.0k 1.5×	768 0.4×	4.9k 2.8×	3.8k 2.2×	413 0.7×	216	8.7k
Kenneth Cornetta United States	46	3.3k 1.6×	3.1k 1.7×	1.3k 0.8×	2.4k 1.4×	516 0.9×	171	7.1k
Esther H. Chang United States	51	5.9k 2.9×	1.9k 1.1×	1.1k 0.6×	3.1k 1.8×	392 0.7×	124	9.6k
Yasushi Ino Japan	32	2.9k 1.4×	1.0k 0.6×	549 0.3×	1.7k 1.0×	172 0.3×	62	6.5k
Yong‐Guang Yang China	50	3.2k 1.5×	1.7k 0.9×	3.8k 2.2×	1.4k 0.8×	2.5k 4.4×	244	9.7k
Karine Breckpot Belgium	54	3.4k 1.6×	1.1k 0.6×	4.5k 2.5×	3.2k 1.9×	211 0.4×	170	7.6k
Boris Fehse Germany	54	5.1k 2.5×	2.8k 1.6×	1.5k 0.9×	2.7k 1.6×	501 0.9×	252	9.2k
Kenneth W. Culver United States	32	4.1k 2.0×	4.4k 2.4×	940 0.5×	2.2k 1.3×	267 0.5×	77	7.0k

Countries citing papers authored by Bernd Gänsbacher

Since Specialization

Citations

This map shows the geographic impact of Bernd Gänsbacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernd Gänsbacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernd Gänsbacher more than expected).

Fields of papers citing papers by Bernd Gänsbacher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernd Gänsbacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernd Gänsbacher. The network helps show where Bernd Gänsbacher may publish in the future.

Co-authorship network of co-authors of Bernd Gänsbacher

This figure shows the co-authorship network connecting the top 25 collaborators of Bernd Gänsbacher. A scholar is included among the top collaborators of Bernd Gänsbacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernd Gänsbacher. Bernd Gänsbacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Reischl, Ilona, Patrick Celis, Nicolas Ferry, et al.. (2017). Clinical Development and Commercialization of Advanced Therapy Medicinal Products in the European Union: How Are the Product Pipeline and Regulatory Framework Evolving?. PubMed. 28(3). 126–135. 39 indexed citations

Tischer, Thomas, Sebastian Aryee, Gabriele Wexel, et al.. (2009). Tissue Engineering of the Anterior Cruciate Ligament—Sodium Dodecyl Sulfate-Acellularized and Revitalized Tendons Are Inferior to Native Tendons. Tissue Engineering Part A. 16(3). 1031–1040. 27 indexed citations

Vogt, Stephan, Gabriele Wexel, Thomas Tischer, et al.. (2009). The influence of the stable expression of BMP2 in fibrin clots on the remodelling and repair of osteochondral defects. Biomaterials. 30(12). 2385–2392. 38 indexed citations

Vogt, Stephan, Peter Ueblacker, Bettina Wagner, et al.. (2008). Efficient and stable gene transfer of growth factors into chondrogenic cells and primary articular chondrocytes using a VSV.G pseudotyped retroviral vector. Biomaterials. 29(9). 1242–1249. 15 indexed citations

Holzbach, Thomas, Dialekti Vlaskou, Moritz A. Konerding, et al.. (2008). Searching for the right timing of surgical delay: angiogenesis, vascular endothelial growth factor and perfusion changes in a skin-flap model. Journal of Plastic Reconstructive & Aesthetic Surgery. 62(11). 1534–1542. 39 indexed citations

Holzbach, Thomas, Dialekti Vlaskou, Moritz A. Konerding, et al.. (2008). Non‐viral VEGF₁₆₅ gene therapy – magnetofection of acoustically active magnetic lipospheres (‘magnetobubbles’) increases tissue survival in an oversized skin flap model. Journal of Cellular and Molecular Medicine. 14(3). 587–599. 34 indexed citations

Martinek, Vladimir, Peter Ueblacker, Katharina Braun, et al.. (2005). Second generation of meniscus transplantation: in-vivo study with tissue engineered meniscus replacement. Archives of Orthopaedic and Trauma Surgery. 126(4). 228–234. 89 indexed citations

Ueblacker, Peter, Bettina Wagner, Achim Krüger, et al.. (2004). Inducible nonviral gene expression in the treatment of osteochondral defects. Osteoarthritis and Cartilage. 12(9). 711–719. 23 indexed citations

Giunta, Riccardo E., Thomas Holzbach, Per Sonne Holm, et al.. (2004). AdVEGF₁₆₅ gene transfer increases survival in overdimensioned skin flaps. The Journal of Gene Medicine. 7(3). 297–306. 43 indexed citations

10.

Elezkurtaj, Sefer, Charlotte Kopitz, Andrew H. Baker, et al.. (2004). Adenovirus‐mediated overexpression of tissue inhibitor of metalloproteinases‐1 in the liver: efficient protection against T‐cell lymphoma and colon carcinoma metastasis. The Journal of Gene Medicine. 6(11). 1228–1237. 23 indexed citations

11.

Anton, Martina, Roland Haubner, Sybille Reder, et al.. (2003). Initial evaluation of a vector coexpressing herpesviral thymidine kinase reporter gene (HSV1-tk) and VEGF for noninvasive imaging of transgene expression. mediaTUM (Technical University of Munich). 1 indexed citations

12.

Banke, In go J., Matthias Arlt, Caroline J. Pennington, et al.. (2003). Increase of Anti-Metastatic Efficacy by Selectivity- But Not Affinity-Optimization of Synthetic Serine Protease Inhibitors. Biological Chemistry. 384(10-11). 1515–25. 7 indexed citations

13.

Gänsbacher, Bernd. (2003). Report of a second serious adverse event in a clinical trial of gene therapy for X‐linked severe combined immune deficiency (X‐SCID). The Journal of Gene Medicine. 5(3). 261–262. 51 indexed citations

14.

Holm, Per Sonne, Stephan Bergmann, Karsten Jürchott, et al.. (2002). YB-1 Relocates to the Nucleus in Adenovirus-infected Cells and Facilitates Viral Replication by Inducing E2 Gene Expression through the E2 Late Promoter. Journal of Biological Chemistry. 277(12). 10427–10434. 90 indexed citations

15.

Haubner, Roland, Norbert Avril, Petros Hantzopoulos, Bernd Gänsbacher, & Markus Schwaiger. (2000). In vivo imaging of herpes simplex virus type 1 thymidine kinase gene expression: early kinetics of radiolabelled FIAU. European Journal of Nuclear Medicine and Molecular Imaging. 27(3). 283–291. 41 indexed citations

16.

Daliani, Danai, Clotilde M. Jackow, William Pugh, et al.. (1998). Tumor Necrosis Factor-α and Interferon-γ, but not HTLV-I Tax, are Likely Factors in the Epidermotropism of Cutaneous T-Cell Lymphoma via Induction of Interferon-Inducible Protein-10. Leukemia & lymphoma. 29(3-4). 315–328. 25 indexed citations

17.

Zier, Karen S. & Bernd Gänsbacher. (1995). The Impact of Gene Therapy on T Cell Function in Cancer. Human Gene Therapy. 6(10). 1259–1264. 22 indexed citations

18.

Rosenthal, Felicia M., Karen S. Zier, & Bernd Gänsbacher. (1994). Human tumor vaccines and genetic engineering of tumors with cytokine and histocompatibility genes to enhance immunogenicity. Current Opinion in Oncology. 6(6). 611–615. 19 indexed citations

19.

Rosenthal, Felicia M., et al.. (1993). Tumor-Bearing Animals Contain Suppressed Antitumor Effectors the Function of Which Can Be Unmasked by IL-2. Journal of Immunotherapy. 14(3). 216–220. 4 indexed citations

20.

Gänsbacher, Bernd, Karen S. Zier, Brian Daniels, et al.. (1990). Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity.. The Journal of Experimental Medicine. 172(4). 1217–1224. 511 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact